Abstract

The aim of the study was to determine the levels of routinely measured liver function tests such as liver enzymes (AST, ALT, ALP, GGT & LDH), serum proteins (albumin and total) and serum bilirubins in patients with Chronic Kidney Disease (CKD). Clinical management of CKD involves frequent laboratory monitoring of liver function tests. It is therefore important to understand the levels of these biochemistry parameters in both healthy individuals and those with CKD for easier and accurate interpretation. A cross-sectional study of two groups of study subjects including patients with CKD and control group was used. A total of 180 subjects with CKD were recruited for the study plus another 200 healthy subjects who served as the control group and were recruited from among blood donors. About 2.0 mL of venous blood specimen was removed from each patient and from control subjects. Levels of the enzymes Aspartate Transaminase (AST), Alkaline Phosphatase (ALP), Alanine Transaminase (ALT), Gamma Glutamyl Transferase (γ-GT) and Lactate Dehydrogenase (LDH) were measured. Levels of serum protein and bilirubin were also determined in the two groups of study subjects. The Kolmogrov-Smirnov test was used to test the data for normality. The data obtained was parametric in nature and was tabulated as a mean and standard deviation. Parametric method of data analysis was used. Descriptive statistics used included parameters of location and parameters of dispersion. Means differences between investigated groups (control and chronic kidney disease patients) were assessed by ANOVA and post Anova statistical analysis. There were statistically significant differences (p<0.05) in the levels of serum protein and liver enzymes between patients with CKD and control group but no significant differences in the levels of serum bilirubin (p>0.05). The results suggest that those patients with CKD exhibited low levels of AST and ALT while the levels of ALP, GGT, and LDH were relatively higher. The levels of serum proteins were relatively lower in patients with CKD as compared to the control group. There is, therefore, the need for a keen interpretation of liver function tests in patients suffering from CKD.

Keywords:

Bilirubin, chronic kidney disease, liver enzymes, liver function tests, serum proteins,

References

1. Bargman, J.M. and K. Skorecki, 2008. Chronic kidney disease. In: Fauci, A.S., E. Braunwald, D.L. Kasper and S.L. Hauser (Eds.), Harrison's Principles of Internal Medicine. Mc Graw Hill, pp: 1761-1771.
   Direct Link
2. Beddhu, S., X. Ma, B. Baird, A.K. Cheung and T. Greene, 2009. Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clin. J. Am. Soc. Nephrol., 4(11): 1805-1810.
   CrossRef    PMid:19729429 PMCid:PMC2774955    
3. Blayney, M.J., R.L. Pisoni, J.L. Bragg-Gresham, J. Bommer, L. Piera et al., 2008. High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int., 74(5): 655-663.
   CrossRef    PMid:18547993    
4. Botev, R. and J.P. Mallie, 2008. Reporting the eGFR and its implication for CKD diagnosis. Clin. J. Am. Soc. Nephrol., 3(6): 1606-1607.
   CrossRef    PMid:18922981    
5. Cain, L.R., A.M. Ducatman and A. Shankar, 2012. The relationship between gamma-glutamyl transferase levels and chronic kidney disease among Appalachian adults. W. V. Med. J., 108(1): 8-13.
   Direct Link
6. Chen, T., Y. Ren, Y. Liu, Y. Long, X. Zhang, H. Yu et al., 2010. Serum gamma-glutamyl transferase, ferritin and the risk of type 2 diabetes in women from a Chinese minority. Diabetes Res. Clin. Pract., 90(3): 352-357.
   CrossRef    PMid:20970869    
7. Eustace, J.A., B. Astor, P.M. Muntner, T.A. Ikizler and J. Coresh, 2004. Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int., 65(3): 1031-1040.
   CrossRef    PMid:14871424    
8. Fabrizi, F., P. Martin and P. Messa, 2010. Hepatitis B and hepatitis C virus and chronic kidney disease. Acta Gastroenterol. Belg., 73(4): 465-471.
   Direct Link
9. Fabrizi, F., P., Martin, G. Lunghi and C. Ponticelli, 2001. Nosocomial transmission of hepatitis C virus infection in hemodialysis patients: Clinical perspectives. Int. J. Artif. Organs, 23(12): 805-816.
   CrossRef    PMid:11197739    
10. Hrstic, I. and R. Ostojic, 2011. Chronic liver diseases in patients with chronic kidney disease. Acta Med. Croatica, 65(4): 349-353.
    Direct Link
11. Kawamoto, R., K. Kohara, Y. Tabara, T. Kusunoki, N. Otsuka and T. Miki, 2008. Association between serum gamma-glutamyl transferase level and prehypertension among community-dwelling men. Tohoku J. Exp. Med., 216(3): 213-221.
    CrossRef    PMid:18987455    
12. Kovesdy, C.P., V. Ureche, J.L. Lu and K. Kalantar-Zadeh, 2010. Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD. Nephrol. Dial. Transplant., 25(9): 3003-3011.
    CrossRef    PMid:20299338 PMCid:PMC2948834    
13. Kovesdy, C.P., 2012. Metabolic acidosis and kidney disease: Does bicarbonate therapy slow the progression of CKD? Nephrol. Dial. Transplant, 27(8): 3056-3062.
    CrossRef    PMid:22851628    
14. Lopes, E.P., L.H. Sette, J.B. Sette, C.F. Luna, A.M. Andrade, M. Moraes et al., 2009. Serum alanine aminotransferase levels, hematocrit rate and body weight correlations before and after hemodialysis session. Clinics, 64(10): 941-945.
    CrossRef    
15. Lwanga, S.K., S. Lemeshow, W. David, Jr. Hosmer and K. Jannelle, 1986. Adequacy of sample size in healthy studies in epidemiological surveys. Bull. World Health Ooganiz., 15: 232-252.
    
16. Mohammadi-Karakani, A., S. Asgharzadeh-Haghighi, M. Ghazi-Khansari and R. Hosseini, 2007. Determination of urinary enzymes as a marker of early renal damage in diabetic patients. J. Clin. Lab. Anal., 21(06): 413-417.https://doi.org/10.1002/jcla.20212
    CrossRef    PMid:18022929    
17. National Kidney Foundation, 2002. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am. J. Kid. Dis., 39: S1-266.
    
18. Ono, K., T. Ono and T. Matsumata, 1995. The pathogenesis of decreased aspartate aminotransferase and alanine aminotransferase activity in the plasma of hemodialysis patients: The role of vitamin B6 deficiency. Clin. Nephrol., 43(6): 405-408.
    Direct Link
19. Perico, N., D. Cattaneo, B. Bikbov and G. Remuzzi, 2009. Hepatitis C infection and chronic renal diseases. Clin. J. Am. Soc. Nephrol., 4(1): 207-220.
    CrossRef    PMid:19129320    
20. Ray, L., S.K. Nanda, A. Chatterjee, R. Sarangi and S. Ganguly, 2015. A comparative study of serum aminotransferases in chronic kidney disease with and without end-stage renal disease: Need for new reference ranges. Int. J. Appl. Basic Med. Res., 5(1): 31-35.
    CrossRef    PMid:25664265 PMCid:PMC4318098    
21. Regidor, D.L., C.P. Kovesdy and R. Mehrotra, 2008. High alkaline phosphatase predicts mortality among maintenance haemodialysis patients. Clin. J. Am. Soc. Nephrol., 19(11): 2193-2203.
    CrossRef    PMid:18667733 PMCid:PMC2573010    
22. Ryu, S., Y. Chang, D.I. Kim, W.S. Kim and B.S. Suh, 2007. Gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin. Chem., 53(1): 71-77.
    CrossRef    PMid:17110470    
23. Sette, L.H. and E.P. Almeida Lopes, 2014. Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: A comprehensive review. Clinics, 69(4): 271-278.
    CrossRef    
24. Sette, L.H. and E.P. Lopes, 2015. The reduction of serum aminotransferase levels is proportional to the decline of the glomerular filtration rate in patients with chronic kidney disease. Clinics, 70(5): 346-349.
    CrossRef    
25. Shantouf, R., C.P. Kovesdy, Y. Kim, N. Ahmadi, A. Luna et al., 2009. Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin. J. Am. Soc. Nephrol., 4(6): 1106-1114.
    CrossRef    PMid:19423565 PMCid:PMC2689878    
26. Taliercio, J.J., J.D. Schold, J.F. Simon, S. Arrigain, A. Tang et al., 2013. Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population. Am. J. Kidney Dis., 62(4): 703-710.
    CrossRef    PMid:23769134 PMCid:PMC3783514    

Competing interests

The authors have no competing interests.

Open Access Policy

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Copyright

The authors have no competing interests.